These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 35114775)
1. Can oligodendrocyte transcriptional factor-2 (Olig2) be used as an alternative for 1p/19q co-deletions to distinguish oligodendrogliomas from other glial neoplasms? Kurdi M; Alkhatabi H; Butt N; Albayjani H; Aljhdali H; Mohamed F; Alsinani T; Baeesa S; Almuhaini E; Al-Ghafari A; Hakamy S; Faizo E; Bahakeem B Folia Neuropathol; 2021; 59(4):350-358. PubMed ID: 35114775 [TBL] [Abstract][Full Text] [Related]
2. 1p19q LOH patterns and expression of p53 and Olig2 in gliomas: relation with histological types and prognosis. Durand KS; Guillaudeau A; Weinbreck N; DeArmas R; Robert S; Chaunavel A; Pommepuy I; Bourthoumieu S; Caire F; Sturtz FG; Labrousse FJ Mod Pathol; 2010 Apr; 23(4):619-28. PubMed ID: 20081802 [TBL] [Abstract][Full Text] [Related]
3. Fluorescence in situ hybridization for 1p, 19q status in a cohort of glial neoplasms. Singh VY; Chacko G; Chacko AG; Rajshekhar V Neurol India; 2014; 62(1):32-6. PubMed ID: 24608451 [TBL] [Abstract][Full Text] [Related]
4. Ancillary FISH analysis for 1p and 19q status: preliminary observations in 287 gliomas and oligodendroglioma mimics. Perry A; Fuller CE; Banerjee R; Brat DJ; Scheithauer BW Front Biosci; 2003 Jan; 8():a1-9. PubMed ID: 12456321 [TBL] [Abstract][Full Text] [Related]
5. 1p/19q co-deleted fibrillary astrocytomas: Not everything that is co-deleted is an oligodendroglioma. Andrews C; Prayson RA Ann Diagn Pathol; 2020 Jun; 46():151519. PubMed ID: 32305004 [TBL] [Abstract][Full Text] [Related]
6. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179 [TBL] [Abstract][Full Text] [Related]
7. [Diagnostic and prognostic roles of loss of CIC protein expression in oligodendroglial tumors]. Liu CC; Zhang LY; Wang LM; Wang DD; Fu YJ; Cai YN; Lu DH; Piao YS Zhonghua Bing Li Xue Za Zhi; 2017 Oct; 46(10):679-683. PubMed ID: 29050068 [No Abstract] [Full Text] [Related]
8. Chromosome 1p and 19q status and p53 and p16 expression patterns as prognostic indicators of oligodendroglial tumors: a clinicopathological study using fluorescence in situ hybridization. Jeon YK; Park K; Park CK; Paek SH; Jung HW; Park SH Neuropathology; 2007 Feb; 27(1):10-20. PubMed ID: 17319279 [TBL] [Abstract][Full Text] [Related]
9. FISHing Tips: What Every Clinician Should Know About 1p19q Analysis in Gliomas Using Fluorescence in situ Hybridisation. Pinkham MB; Telford N; Whitfield GA; Colaco RJ; O'Neill F; McBain CA Clin Oncol (R Coll Radiol); 2015 Aug; 27(8):445-53. PubMed ID: 25971646 [TBL] [Abstract][Full Text] [Related]
10. Quantitation of chromosome 1p and 19q deletions in glial tumours by interphase FISH on formalin-fixed paraffin-embedded tissue. Gonzales M; Dale S; Susman M; Mills J J Clin Neurosci; 2006 Jan; 13(1):96-101. PubMed ID: 16410204 [TBL] [Abstract][Full Text] [Related]
11. High Carbonic Anhydrase-9 Expression Identifies a Subset of 1p/19q Co-Deletion and Favorable Prognosis in Oligodendroglioma. Sathornsumetee S; Cheunsuchon P; Sangruchi T World Neurosurg; 2016 Jul; 91():518-523.e1. PubMed ID: 26960282 [TBL] [Abstract][Full Text] [Related]
12. Is the 1p/19q deletion a diagnostic marker of oligodendrogliomas? Gadji M; Fortin D; Tsanaclis AM; Drouin R Cancer Genet Cytogenet; 2009 Oct; 194(1):12-22. PubMed ID: 19737649 [TBL] [Abstract][Full Text] [Related]
13. Alpha-internexin and altered CIC expression as a supportive diagnostic marker for oligodendroglial tumors with the 1p/19q co-deletion. Nagaishi M; Suzuki A; Nobusawa S; Yokoo H; Nakazato Y Brain Tumor Pathol; 2014 Oct; 31(4):257-64. PubMed ID: 24197863 [TBL] [Abstract][Full Text] [Related]
14. Losses of chromosomal arms 1p and 19q in the diagnosis of oligodendroglioma. A study of paraffin-embedded sections. Burger PC; Minn AY; Smith JS; Borell TJ; Jedlicka AE; Huntley BK; Goldthwaite PT; Jenkins RB; Feuerstein BG Mod Pathol; 2001 Sep; 14(9):842-53. PubMed ID: 11557779 [TBL] [Abstract][Full Text] [Related]
15. [Correlation of chromosome 1p and 19q status and expression of R132H mutant IDH1 protein in oligodendroglial tumors]. Yao K; Duan Z; Hu Z; Bian Y; Qi X Zhonghua Bing Li Xue Za Zhi; 2014 Oct; 43(10):663-7. PubMed ID: 25567591 [TBL] [Abstract][Full Text] [Related]
16. Eighty percent survival rate at 15 years for 1p/19q co-deleted oligodendroglioma treated with upfront chemotherapy irrespective of tumor grade. Iwadate Y; Matsutani T; Hara A; Hirono S; Ikegami S; Kobayashi M; Ito D; Kawauchi D; Horiguchi K; Tamiya A; Higuchi Y J Neurooncol; 2019 Jan; 141(1):205-211. PubMed ID: 30565028 [TBL] [Abstract][Full Text] [Related]
17. [Diagnostic and prognostic values of 1p and 19q deletions in adult gliomas: critical review of the literature and implications in daily clinical practice]. Fontaine D; Vandenbos F; Lebrun C; Paquis V; Frenay M Rev Neurol (Paris); 2008; 164(6-7):595-604. PubMed ID: 18565359 [TBL] [Abstract][Full Text] [Related]
18. Application of brush cytology for FISH-based detection of 1p/19q codeletion in oligodendroglial tumors. Srebotnik-Kirbiš I; Limbäck-Stokin C J Neurooncol; 2016 Sep; 129(3):415-422. PubMed ID: 27406587 [TBL] [Abstract][Full Text] [Related]
19. Network-based analysis of oligodendrogliomas predicts novel cancer gene candidates within the region of the 1p/19q co-deletion. Gladitz J; Klink B; Seifert M Acta Neuropathol Commun; 2018 Jun; 6(1):49. PubMed ID: 29890994 [TBL] [Abstract][Full Text] [Related]
20. Nogo-A: a useful marker for the diagnosis of oligodendroglioma and for identifying 1p19q codeletion. Marucci G; Di Oto E; Farnedi A; Panzacchi R; Ligorio C; Foschini MP Hum Pathol; 2012 Mar; 43(3):374-80. PubMed ID: 21835431 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]